MedTrace Logo

Biomarkers of Brain Injury: Magnitude and Outcome of Mild and Moderate TBI

NCT01786447 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 111

Last updated 2013-02-12

No results posted yet for this study

Summary

The purpose of this study is to determine if specific brain injury biomarkers have utility as blood-based traumatic brain injury (TBI) diagnostic and monitoring tools. This will be accomplished by examining the relationships between potential serum-based TBI biomarkers and clinical measures of injury severity, occurrence of complications, and outcome, in subjects with mild or moderate TBI as well as in orthopedic control subjects.

Conditions

  • Brain Injuries, Traumatic

Sponsors & Collaborators

  • Banyan Biomarkers, Inc

    lead INDUSTRY

Principal Investigators

  • Jackson Streeter, MD · Banyan Biomarkers

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-04-30
Primary Completion
2011-03-31
Completion
2011-03-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01786447 on ClinicalTrials.gov